PharmaLogic
PharmaLogic Development is a privately held San Rafael, California-based consultancy providing strategic and tactical drug development consulting for pharmaceutical and medical device companies, with particular expertise in ophthalmology, dermatology, and neurology. The firm serves 600+ clients globally across the regulatory, clinical, and medical writing spectrum.
- Company typePrivate
- Founded1984
- HeadquartersSan Rafael, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What PharmaLogic does
PharmaLogic Development, Inc. is a privately held pharmaceutical and medical device consultancy headquartered in San Rafael, California, founded approximately 40 years ago by Gary D. Novack, Ph.D. The firm provides strategic direction and tactical execution for development of novel pharmaceuticals, biologics, and medical devices, with particular expertise in local therapy areas of ophthalmology and dermatology, and additional experience in neurology. Service offerings span drug development planning, clinical trial design, regulatory submissions (INDs, IDEs, NDAs, PMAs), FDA client representation, scientific communications and medical writing, safety assessment, and licensing representation. The firm has contributed to over 40 approved products, over 120 IND and IDE submissions, and over 360 published papers, with Dr. Novack individually authoring over 400 publications.
The firm operates as a professional services consultancy with a sales-led go-to-market model built primarily on professional networks, academic conferences (ARVO, AAO, AOPT, American Glaucoma Society), and direct consulting engagements. Pricing is quote-based and negotiated per project, with no public pricing disclosure. The client base spans over 600 pharmaceutical and medical device companies across four continents, with named clients including Zhaoke Ophthalmology Limited and Glaukos Corporation. Marketing and brand building is conducted almost entirely through Dr. Novack's personal publication record, speaking engagements, editorial board positions, and media appearances including The New York Times and UC Davis Health. Distribution is relationship-based direct engagement rather than product distribution.
PharmaLogic is a founder-led, lean organization (11-50 employees) with no identified parent company, no institutional investment, no funding rounds, and no M&A activity. The core team consists of Dr. Novack as President and Dona Ann Novack as Director of Information Services, supported by a team of senior experts. The business model is fundamentally tied to Dr. Novack's personal expertise, academic affiliations (UC Davis Professor and Vice Chair of Collaborative Research), and industry credentials (Fellow of ARVO, AOPT, American College of Clinical Pharmacology). This concentrated key-person dependency is both the firm's primary asset and its most significant structural limitation.
PharmaLogic firmographics
Firmographics- Name
- PharmaLogic
- Legal name
- PharmaLogic Development, Inc.
- Website
- https://pharmalogic.com
- Company type
- Private
- Founded year
- 1984
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- PharmaLogic Development is a privately held San Rafael, California-based consultancy providing strategic and tactical drug development consulting for pharmaceutical and medical device companies, with particular expertise in ophthalmology, dermatology, and neurology. The firm serves 600+ clients globally across the regulatory, clinical, and medical writing spectrum.
- Ownership category
- akta.pro rank
PharmaLogic industry classification
Industry- Product category
- Pharmaceutical Consulting Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Ophthalmology Pharmaceuticals (HLAIAAAL)
- akta.pro secondary industry
- Specialty Care Pharmaceuticals (HLAIAAAB)
Keywords
Where PharmaLogic is headquartered
LocationHeadquarters
- HQ city
- San Rafael
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
PharmaLogic business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Consulting Services: PharmaLogic provides strategic direction and tactical execution for development of novel pharmaceuticals and medical devices. Services include drug development planning, clinical trial design, regulatory submissions (INDs, IDEs, NDAs, PMAs), scientific publications, and business development consulting. The firm works with pharmaceutical and medical device companies from candidate selection through NDA and marketing support.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
PharmaLogic product offering
Product offeringCore offering
PharmaLogic Development, Inc. is a consultancy providing strategic direction and tactical execution for development of novel pharmaceuticals and medical devices. Services span drug development planning, clinical trial design, regulatory submissions (INDs, IDEs, NDAs, PMAs), preclinical data review, candidate selection, licensing representation, scientific/medical writing, and FDA client representation, with particular expertise in local therapy (ophthalmology and dermatology).
Product overview
PharmaLogic Development, Inc. is a consultancy that provides strategic direction and tactical execution for development of novel pharmaceuticals and medical devices. The company does not offer a software product or platform, but rather provides consulting services including regulatory affairs (NDA/Preclinical and clinical reports, FDA client representation), clinical trials support (Trial Outlines, Protocol Design, Biostatistical Evaluation, Medical Final Reports), and product research and development (Preclinical Data Review, Candidate Selection, Licensing Representation, Business Plans, IND Preparation). Their primary therapeutic areas are ophthalmology, dermatology, and neurology. The firm has contributed to over 40 approved products in these therapeutic areas and has served over 600 clients on four continents.
Differentiator
Problem solved
Functional benefit
Products and services
- Drug Development Planning Consulting Strategic consulting on drug development planning from candidate selection through regulatory approval, helping pharmaceutical and medical device companies navigate the complex, expensive, and risky medical product development journey.
- FDA Regulatory Submission Services Preparation and submission of regulatory filings to the FDA, including Investigational New Drug (IND) applications, Investigational Device Exemptions (IDEs), New Drug Applications (NDAs), and Premarket Approvals (PMAs), along with FDA client representation.
- Clinical Trial Design Services Consulting on clinical trial outlines, protocol design, biostatistical evaluation, and medical final reports for pharmaceutical and medical device development programs.
- Medical Writing and Scientific Publications Medical writing and scientific publication services for pharmaceutical and medical device clients, including preparation of manuscripts, regulatory documents, and clinical reports for publication in peer-reviewed journals.
- Preclinical Data Review and Candidate Selection Consulting on preclinical data review and candidate selection to support pharmaceutical and medical device development decision-making, including formulation (pharmaceutics), safety assessment, and clinical planning integration.
- Licensing Representation and Business Plans Product licensing representation and business plan development for pharmaceutical and medical device companies seeking to commercialize or partner assets under development.
Quantifiable outcome
- Over 40 approved products developed with client contributions
- +3 more outcomes
Companies that use PharmaLogic
Customer profileNamed customers3 records
Segments1 record
Ideal customer profiles1 record
PharmaLogic technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
PharmaLogic partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Zhaoke Ophthalmology LimitedminorPharmaLogic Development, Inc. was contracted to provide service to Zhaoke Ophthalmology Limited in their ophthalmic product development. This represents a client-service relationship where PharmaLogic provides consulting expertise.
Scale indicators7 records
Recent moves6 records
Expansion highlights4 records
PharmaLogic competitors and assessment
Company assessmentDirect peers
- Ora, Inc. Ora is a clinical research organization specializing in ophthalmology and ENT drug and device development. It is the most direct peer to PharmaLogic because both firms concentrate regulatory, clinical, and product-development expertise in the ophthalmology therapeutic area for which PharmaLogic is best known.
- Camargo Pharmaceutical Services: Camargo specializes in regulatory affairs consulting for the pharmaceutical industry, with particular strength in 505(b)(2) development and complex generic programs. It is a direct peer because it directly competes for the same regulatory strategy and FDA submission engagements that are core to PharmaLogic's offering.
- ProPharma Group: ProPharma Group is a pharmaceutical consulting firm providing regulatory affairs, clinical research, and compliance support across drug development lifecycle. It is a direct peer because it competes with PharmaLogic for the same pharma sponsor consulting engagements and offers overlapping services like IND/NDA preparation.
- Advanced Clinical: Advanced Clinical is a CRO and clinical development services firm working with biotech and mid-sized pharma sponsors. It is a direct peer because it serves a similar client profile of small and mid-sized pharma/biotech sponsors seeking outsourced development support, including clinical and regulatory services.
- Nuventra Pharma Sciences: Nuventra is a clinical pharmacology and drug development consulting firm supporting small and mid-sized pharma companies. It is a direct peer because it operates in the same small-consultant niche of clinical pharmacology and regulatory strategy that PharmaLogic serves.
Broad incumbents
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO providing clinical trial management and drug development services across multiple therapeutic areas. It is a broad incumbent peer because it competes for outsourced development engagements that include the kind of regulatory strategy work PharmaLogic provides to sponsors.
- Charles River Laboratories: Charles River Laboratories provides early-stage drug discovery, preclinical, and clinical development services to pharma and biotech sponsors. It is a broad incumbent peer because it covers portions of the development value chain — particularly preclinical and early clinical — that touch PharmaLogic's consulting scope.
- ICON plc: ICON is a global CRO providing a broad range of drug development and consulting services to pharma and biotech sponsors. It is a broad incumbent peer because it competes for outsourced drug development engagements and offers services adjacent to PharmaLogic's regulatory and clinical strategy offerings.
- Medpace: Medpace is a mid-sized global CRO offering full-service clinical development across therapeutic areas. It is a broad incumbent peer because, while not ophthalmology-specialized, it provides drug development services that overlap with PharmaLogic's value proposition for sponsors seeking consolidated development support.
- IQVIA: IQVIA is the largest global CRO and clinical development services provider with a comprehensive portfolio spanning R&D, regulatory, and commercial services. It is a broad incumbent peer because it competes for the same outsourced drug development work and increasingly offers specialized therapeutic-area advisory services.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
PharmaLogic social profiles
Digital presencePharmaLogic financial estimates
Financial estimateRevenue estimate
Valuation estimate
PharmaLogic leadership team
Management profileNumber of profiles
Profiles2 records
PharmaLogic funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PharmaLogic M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PharmaLogic
What does PharmaLogic do?
PharmaLogic Development, Inc. is a consultancy providing strategic direction and tactical execution for development of novel pharmaceuticals and medical devices. Services span drug development planning, clinical trial design, regulatory submissions (INDs, IDEs, NDAs, PMAs), preclinical data review, candidate selection, licensing representation, scientific/medical writing, and FDA client representation, with particular expertise in local therapy (ophthalmology and dermatology).
Is PharmaLogic a public or private company?
PharmaLogic is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was PharmaLogic founded?
PharmaLogic was founded in 1984. It employs 11 to 50 people.
Where is PharmaLogic based?
PharmaLogic is headquartered in San Rafael, United States, in the North America region.
How does PharmaLogic make money?
One revenue line is on record: consulting Services.
Who are PharmaLogic's main competitors?
Direct peers on record are Ora, Inc., Camargo Pharmaceutical Services, ProPharma Group, Advanced Clinical and Nuventra Pharma Sciences. Broad incumbents are Worldwide Clinical Trials, Charles River Laboratories, ICON plc, Medpace and IQVIA.
Does PharmaLogic have an API?
No public API is recorded for PharmaLogic.
What industry is PharmaLogic in?
PharmaLogic's product category is Pharmaceutical Consulting Services. Its primary akta.pro industry code is HLAIAAAL, Ophthalmology Pharmaceuticals, with a secondary code of HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 5417 and its SIC code is 8000.